Main Benefits of Using Whole Genome Sequencing (WGS) Over Microarray

Whole genome sequencing (WGS) and microarray-based approaches each have distinct advantages depending on research goals, budget, and the types of genomic variants of interest. While microarrays are cost-effective and provide high-throughput genotyping of known variants, WGS offers several important benefits that microarrays cannot match. Below are the main advantages of using WGS over microarray.

1. Comprehensive Variant Detection

Known and Novel Variants: Microarrays rely on probes for known variants, meaning they only detect what has been pre-selected for the array. WGS, on the other hand, sequences the entire genome without bias, enabling the discovery of:

• Novel single-nucleotide variants (SNVs)
• Rare variants not present on commercial arrays
• Variants in underrepresented populations (e.g., non-European ancestry)

Structural Variants: WGS can identify structural changes that microarrays typically miss or only approximate, such as:

• Large insertions and deletions (indels)
• Copy number variations (CNVs)
• Translocations and inversions

2. Better Resolution and Sensitivity

Base-Level Resolution: WGS can theoretically capture every base in the genome, offering complete insight into genetic variation. This level of detail is crucial for many research and clinical applications where precise mutation positions matter.

Coverage of Difficult Regions: Modern WGS technologies continue to improve coverage in hard-to-sequence regions, such as those with repetitive sequences. In contrast, microarrays often have limited or no probe coverage in repetitive or GC-rich regions, leading to incomplete variant detection.

3. Versatility for Multiple Applications

One Data Set, Many Uses: Once you have a WGS data set, you can re-analyze it for a wide range of questions:

• Identifying additional mutations associated with disease phenotypes
• Re-examining genome-wide variation in the context of new discoveries
• Integrative analyses with other omics data (e.g., transcriptomics)

Future-Proofing: Because WGS captures all variants (not just known ones), the data can be re-mined when new genetic associations are discovered, eliminating the need to generate new data for novel loci.

4. No Dependence on Reference Panels or Probe Design

No Probe Bias: Microarrays depend on pre-designed probes. Poorly designed probes or probes targeting polymorphic sites can yield partial or inaccurate genotype calls. WGS avoids these issues entirely by sequencing without requiring specialized probes.

Reduced Bias from Population Allele Frequencies: Microarray panels are often optimized for certain populations (e.g., European reference allele frequencies). WGS does not assume prior knowledge of allele frequencies, making it more equitable for diverse populations.

5. Improved Accuracy for Complex Loci

Haplotyping and Phasing: Newer WGS approaches (e.g., long-read or linked-read technologies) can improve haplotyping and phasing, helping researchers discern which variants occur on the same chromosome copy. This is vital for understanding compound heterozygosity and other complex genetic interactions.

Mitochondrial and Other Non-Canonical Genomes: WGS can also cover mitochondrial DNA and, depending on the protocol, detect viral or bacterial co-infections in metagenomic samples, offering a broader picture of genomic content.

6. Greater Diagnostic Potential

Clinical Applications: In a diagnostic setting, WGS is especially valuable for:

• Rare disease research (where disease-causing variants might not be covered by typical arrays)
• Cancer genomics (detection of tumor-specific mutations, structural variants, and copy number changes)

Precision Medicine: By providing a complete catalog of an individual’s genomic variants, WGS can facilitate more personalized treatments and risk assessments, especially as large-scale genomic datasets become common in healthcare.

Key Takeaways

1. Discovery of Novel Variants: WGS is not constrained by pre-selected probes, making it superior for identifying new and rare mutations.
2. Comprehensive and Flexible Data: Whole genome coverage allows for in-depth analyses of structural variants, difficult genomic regions, and re-analysis as new discoveries arise.
3. Clinical Utility: Particularly useful in rare disease and oncology settings, where full genomic detail can offer crucial insights for diagnosis and treatment.

While WGS is typically more expensive and computationally demanding than standard microarrays, the rapid decrease in sequencing costs and ongoing improvements in data analysis pipelines have made it increasingly accessible for both research and clinical applications. For those seeking the fullest possible picture of genomic variation, the benefits of WGS clearly outweigh the limitations of microarrays.

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Receive your NutraHacker free Methylation and Detoxification report here: Upload raw DNA microarray data